Patrick Trucchio
Recent Articles about Arrowhead Pharmaceuticals Inc.
Analyst Says CA Pharma Underappreciated by Investors 07/23/2024
Arrowhead Pharmaceuticals Inc. (ARWR:NASDAQ) recently hosted a webinar going over its pulmonary programs. Read on to see why an H.C. Wainwright & Co. analyst believes the company is underappreciated by investors.
© 2024 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
